A novel TNKS inhibitor JW55 directly inhibited the PARP domain of TNKS1/2, leading to increased degradation of β‐catenin to reduce colorectal tumor growth in conditional APC‐mutant mice model [248]. The gene discussed is TNKS; the disease is colorectal neoplasm.